The following is a summary of “Time to Renal Replacement Therapy Initiation in Critically Ill Patients With Acute Kidney ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Swedish biotechnology company Hansa Biopharma has finished enrolling subjects in a Phase III trial in Europe evaluating ...

An expert discusses how third line (3L) systemic therapy for metastatic renal cell carcinoma (mRCC) is guided by prior ...

Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Inherited kidney diseases and congenital anomalies of the kidney and urinary tract (CAKUT) warrant special attention.